Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Completed Phase 1 Trials for Lenalidomide (DB00480)

IndicationStatusPhase
DBCOND0029297 (Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00100880Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS TumorsTreatment